DEA Chronicles welcomes guest blogger Julia Hudson, a Q&B Health Law attorney.
On September 30, 2015, the Improving Regulatory Transparency for New Medical Therapies Act moved one step closer to becoming federal law by passing the Senate Health, Education, Labor and Pensions Committee. The bill, which was introduced on February 2, 2015 and passed